Clinical Biomarker of Paclitaxel-induced Peripheral Neuropathy

NCT06430814 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 188

Last updated 2025-09-02

No results posted yet for this study

Summary

Investigation of which patients treated with paclitaxel have an increased risk of developing peripheral neuropathy.

Conditions

  • Chemotherapy-induced Peripheral Neuropathy

Interventions

OTHER

No intervention

No intervention

Sponsors & Collaborators

  • Odense University Hospital

    collaborator OTHER
  • Sygehus Lillebaelt

    collaborator OTHER
  • Sonderborg Hospital

    collaborator OTHER_GOV
  • University of Southern Denmark

    lead OTHER

Principal Investigators

  • Ditte Bork Iversen · University of Southern Denmark

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-10-10
Primary Completion
2027-09-30
Completion
2027-09-30

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06430814 on ClinicalTrials.gov